Prescription Rifampin Capsules Recalled for Failed Impurity Specifications
Lupin Pharmaceuticals is recalling Rifampin Capsules (300 mg) nationwide due to failed impurity and degradation specifications found during stability testing. Lot A200171 (exp. 12/2023) is affected, with over 16,000 bottles distributed.
- Product
- RIFAMPIN — RIFAMPIN (RIFAMPIN)
- Category
- Drug
- Distribution
- Distributed nationwide